rapcabtagene autoleucel
novartis
['elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'ytb 323', 'rapcabtagene', 'ytb323', 'dlbcl']
ytb 323 rapid car t, n =47, ?? 68% required bridging therapy(not so rapid manufacturing) dose level 2, 12.5 million cells, orr 80%, long term cr 50% #ash22, tcharge platform 
MD